medicine

What Is the Price of a Prescription Drug?

Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is...

Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be

New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.

LATEST NEWS

Missing the Forest for the Trees: A Reply to Hovenkamp and Shapiro

The Federal Trade Commission’s now-abandoned 2020 Vertical Merger Guidelines were not some ideal economic document that the FTC foolishly disregarded; rather, they...

Buchanan’s Samaritan’s Dilemma

The Samaritan’s dilemma is not only about the detrimental effects help can have on the beneficiaries. As James Buchanan explained in his...

How Will the FTC Evaluate Vertical Mergers?

The Federal Trade Commission’s recent withdrawal of its 2020 vertical merger guidelines is flatly incorrect as a matter of microeconomic theory and...

Announcing the Participants in the Fall 2021 Stigler Center Journalists in Residence Program

This month, the Stigler Center will welcome eight world-class journalists from the United Kingdom, Brazil, China, Romania, Ukraine, Slovenia, and the United...

The Roots of America’s Competition Revolution

Proponents of the current transformation in America’s competition policy managed to shape legislative reform proposals, push public antitrust agencies to boost enforcement, and successfully...